{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:23:05Z","timestamp":1772119385894,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Research Foundation funded by the Ministry of Education, Republic of Korea","award":["NRF-2013R1A1A2013480"],"award-info":[{"award-number":["NRF-2013R1A1A2013480"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00520-025-10041-7","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:04:07Z","timestamp":1760457847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal trajectory of menopausal symptoms in premenopausal women throughout adjuvant chemotherapy: a two-stage analytical approach"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6543-9917","authenticated-orcid":false,"given":"Saim","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6553-9563","authenticated-orcid":false,"given":"Jaehyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8559-8117","authenticated-orcid":false,"given":"Sun Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2425-4406","authenticated-orcid":false,"given":"Joon Sung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6650-3685","authenticated-orcid":false,"given":"Won-Hyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5381-4847","authenticated-orcid":false,"given":"Dooyoung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3930-6766","authenticated-orcid":false,"given":"Tae-Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5396-6533","authenticated-orcid":false,"given":"Seock-Ah","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2390-3240","authenticated-orcid":false,"given":"Kyung-Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2366-3275","authenticated-orcid":false,"given":"Bong-Jin","family":"Hahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2265-3291","authenticated-orcid":false,"given":"Chan-Woo","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"9472","key":"10041_CR1","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Group, E.B.C.T.C.","year":"2005","unstructured":"Group, E.B.C.T.C. (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687\u20131717","journal-title":"Lancet"},{"issue":"1","key":"10041_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.critrevonc.2013.07.007","volume":"89","author":"F Torino","year":"2014","unstructured":"Torino F et al (2014) Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. Crit Rev Oncol Hematol 89(1):27\u201342","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10041_CR3","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1634\/theoncologist.11-5-422","volume":"11","author":"M Sonmezer","year":"2006","unstructured":"Sonmezer M, Oktay K (2006) Fertility preservation in young women undergoing breast cancer therapy. Oncologist 11(5):422\u2013434","journal-title":"Oncologist"},{"key":"10041_CR4","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1007\/s00268-014-2542-y","volume":"38","author":"V Tiong","year":"2014","unstructured":"Tiong V et al (2014) Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer. World J Surg 38:2288\u20132296","journal-title":"World J Surg"},{"issue":"22","key":"10041_CR5","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMoa0909638","volume":"362","author":"SM Swain","year":"2010","unstructured":"Swain SM et al (2010) Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 362(22):2053\u20132065","journal-title":"N Engl J Med"},{"key":"10041_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.859974","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y et al (2022) Chemotherapy-induced amenorrhea and its prognostic significance in premenopausal women with breast cancer: an updated meta-analysis. Front Oncol 12:859974","journal-title":"Front Oncol"},{"issue":"5","key":"10041_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/annonc\/mdp394","volume":"21","author":"HM Fan","year":"2010","unstructured":"Fan HM et al (2010) Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study. Ann Oncol 21(5):983\u2013987","journal-title":"Ann Oncol"},{"issue":"11","key":"10041_CR8","doi-asserted-by":"publisher","first-page":"e2343910","DOI":"10.1001\/jamanetworkopen.2023.43910","volume":"6","author":"R Kabirian","year":"2023","unstructured":"Kabirian R et al (2023) Chemotherapy-related amenorrhea and quality of life among premenopausal women with breast cancer. JAMA Netw Open 6(11):e2343910\u2013e2343910","journal-title":"JAMA Netw Open"},{"key":"10041_CR9","unstructured":"Korean Breast Cancer Society. Breast cancer facts & figures 2013. Seoul: Korean Breast Cancer Society; 2013. pp 4\u201313."},{"issue":"2","key":"10041_CR10","first-page":"101","volume":"11","author":"DR Youlden","year":"2014","unstructured":"Youlden DR et al (2014) Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med 11(2):101","journal-title":"Cancer Biol Med"},{"issue":"10","key":"10041_CR11","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1001\/jamaoncol.2019.0620","volume":"5","author":"Y-S Yap","year":"2019","unstructured":"Yap Y-S et al (2019) Insights into breast cancer in the east vs the west: a review. JAMA Oncol 5(10):1489\u20131496","journal-title":"JAMA Oncol"},{"issue":"4","key":"10041_CR12","doi-asserted-by":"publisher","first-page":"867","DOI":"10.31557\/APJCP.2020.21.4.867","volume":"21","author":"HJ Youn","year":"2020","unstructured":"Youn HJ, Han W (2020) A review of the epidemiology of breast cancer in Asia: focus on risk factors. Asian Pacific J Cancer Prevention: APJCP 21(4):867","journal-title":"Asian Pacific J Cancer Prevention: APJCP"},{"issue":"3","key":"10041_CR13","first-page":"167","volume":"5","author":"P Suprasert","year":"2020","unstructured":"Suprasert P, Khunthong P, Somwangprasert A (2020) Prevalence and potential factors related to irreversible chemotherapy-induced amenorrhea in premenopausal breast cancer patients. Asian Pac J Cancer Care 5(3):167\u2013172","journal-title":"Asian Pac J Cancer Care"},{"key":"10041_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10549-008-0071-9","volume":"115","author":"H-S Han","year":"2009","unstructured":"Han H-S et al (2009) Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer. Breast Cancer Res Treat 115:335\u2013342","journal-title":"Breast Cancer Res Treat"},{"issue":"30","key":"10041_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/oxfordjournals.jncimonographs.a003451","volume":"2001","author":"AH Partridge","year":"2001","unstructured":"Partridge AH, Burstein HJ, Winer EP (2001) Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. JNCI Monogr 2001(30):135\u2013142","journal-title":"JNCI Monogr"},{"key":"10041_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-2-67","volume":"2","author":"LA Heinemann","year":"2004","unstructured":"Heinemann LA et al (2004) The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes 2:1\u20137","journal-title":"Health Qual Life Outcomes"},{"key":"10041_CR17","unstructured":"World Health Organization. Research on the menopause: report of a WHO scientific group (meeting held in Geneva, 8\u201312 December 1980). Geneva: World Health Organization; 1981."},{"key":"10041_CR18","unstructured":"Oh SM, Min KJ, Park DB. A study on the standardization of the hospital anxiety and depression scale for Koreans: a comparison of normal, depressed and anxious groups.\u00a0J Korean Neuropsychiatr Assoc. 1999;38:289\u201396."},{"issue":"6","key":"10041_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370","journal-title":"Acta Psychiatr Scand"},{"issue":"36","key":"10041_CR20","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1200\/JCO.2006.07.2793","volume":"24","author":"JM Walshe","year":"2006","unstructured":"Walshe JM, Denduluri N, Swain SM (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24(36):5769\u20135779","journal-title":"J Clin Oncol"},{"key":"10041_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00280-013-2227-5","volume":"72","author":"C Yoo","year":"2013","unstructured":"Yoo C et al (2013) Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study. Cancer Chemother Pharmacol 72:565\u2013575","journal-title":"Cancer Chemother Pharmacol"},{"key":"10041_CR22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s12282-017-0764-1","volume":"24","author":"C Koga","year":"2017","unstructured":"Koga C et al (2017) Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer. Breast Cancer 24:714\u2013719","journal-title":"Breast Cancer"},{"key":"10041_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7819-11-101","volume":"11","author":"K Meng","year":"2013","unstructured":"Meng K et al (2013) Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levels. World J Surg Oncol 11:1\u20137","journal-title":"World J Surg Oncol"},{"key":"10041_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.572388","volume":"11","author":"D Mauri","year":"2020","unstructured":"Mauri D et al (2020) Chemotherapy associated ovarian failure. Front Endocrinol 11:572388","journal-title":"Front Endocrinol"},{"key":"10041_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1210\/rp.57.1.257","volume":"57","author":"HG Burger","year":"2002","unstructured":"Burger HG et al (2002) Hormonal changes in the menopause transition. Recent Prog Horm Res 57:257\u2013276","journal-title":"Recent Prog Horm Res"},{"issue":"5","key":"10041_CR26","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.fertnstert.2007.09.048","volume":"90","author":"A Reh","year":"2008","unstructured":"Reh A, Oktem O, Oktay K (2008) Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril 90(5):1635\u20131639","journal-title":"Fertil Steril"},{"issue":"5","key":"10041_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa037","volume":"4","author":"W Shi","year":"2020","unstructured":"Shi W et al (2020) Inflammatory biomarkers, hematopoietic stem cells, and symptoms in breast cancer patients undergoing adjuvant radiation therapy. JNCI Cancer Spectr 4(5):pkaa037","journal-title":"JNCI Cancer Spectr"},{"issue":"13","key":"10041_CR28","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.3390\/cancers15133407","volume":"15","author":"AI Hoogland","year":"2023","unstructured":"Hoogland AI et al (2023) Relationships among inflammatory biomarkers and self-reported treatment-related symptoms in patients treated with chemotherapy for gynecologic cancer: a controlled comparison. Cancers 15(13):3407","journal-title":"Cancers"},{"key":"10041_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156632","volume":"179","author":"MM Bakheet","year":"2024","unstructured":"Bakheet MM, Ali HM, Talab TJ (2024) Evaluation of some proinflammatory cytokines and biochemical parameters in pre and postmenopausal breast cancer women. Cytokine 179:156632","journal-title":"Cytokine"},{"key":"10041_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2023.100119","author":"U Langeh","year":"2023","unstructured":"Langeh U et al (2023) An update on breast cancer chemotherapy-associated toxicity and their management approaches. Health Sciences Review. https:\/\/doi.org\/10.1016\/j.hsr.2023.100119","journal-title":"Health Sciences Review"},{"key":"10041_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12609-017-0245-8","volume":"9","author":"TE Lacourt","year":"2017","unstructured":"Lacourt TE, Heijnen CJ (2017) Mechanisms of neurotoxic symptoms as a result of breast cancer and its treatment: considerations on the contribution of stress, inflammation, and cellular bioenergetics. Curr Breast Cancer Rep 9:70\u201381","journal-title":"Curr Breast Cancer Rep"},{"key":"10041_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.bbi.2014.02.010","volume":"38","author":"AK Smith","year":"2014","unstructured":"Smith AK et al (2014) Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy. Brain Behav Immun 38:227\u2013236","journal-title":"Brain Behav Immun"},{"key":"10041_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1415","author":"A Pitman","year":"2018","unstructured":"Pitman A et al (2018) Depression and anxiety in patients with cancer. BMJ. https:\/\/doi.org\/10.1136\/bmj.k1415","journal-title":"BMJ"},{"key":"10041_CR34","doi-asserted-by":"crossref","unstructured":"DiMatteo MR, Haskard-Zolnierek KB. Impact of depression on treatment adherence and survival from cancer. In: Depression and Cancer. Chichester: Wiley-Blackwell; 2011. pp. 101\u201324.","DOI":"10.1002\/9780470972533.ch5"},{"issue":"1","key":"10041_CR35","first-page":"155","volume":"103","author":"J Abdo","year":"2023","unstructured":"Abdo J et al (2023) Quality of life issues following breast cancer treatment. Surg Clin 103(1):155\u2013167","journal-title":"Surg Clin"},{"key":"10041_CR36","first-page":"1","volume-title":"Tasman\u2019s Psychiatry","author":"DC McFarland","year":"2023","unstructured":"McFarland DC, Alici Y (2023) Consultation-Liaison Psychiatry and Psychological Factors Affecting Other Medical Conditions. Tasman\u2019s Psychiatry. Springer, pp 1\u201336"},{"issue":"Suppl 2","key":"10041_CR37","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_1019_21","volume":"64","author":"S Gautam","year":"2022","unstructured":"Gautam S et al (2022) Overview of practice of consultation-liaison psychiatry. Indian J Psychiatry 64(Suppl 2):S201\u2013S210","journal-title":"Indian J Psychiatry"},{"issue":"12","key":"10041_CR38","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1176\/appi.ajp.159.12.1964","volume":"159","author":"DS Kornfeld","year":"2002","unstructured":"Kornfeld DS (2002) Consultation-liaison psychiatry: contributions to medical practice. Am J Psychiatry 159(12):1964\u20131972","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10041_CR39","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/pon.867","volume":"13","author":"W S\u00f6llner","year":"2004","unstructured":"S\u00f6llner W et al (2004) Providing psychosocial support for breast cancer patients based on screening for distress within a consultation-liaison service. Psycho-Oncol 13(12):893\u2013897","journal-title":"Psycho-Oncol"},{"issue":"9247","key":"10041_CR40","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","volume":"356","author":"CL Loprinzi","year":"2000","unstructured":"Loprinzi CL et al (2000) Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356(9247):2059\u20132063","journal-title":"Lancet"},{"issue":"10","key":"10041_CR41","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1093\/annonc\/mdn353","volume":"19","author":"M Hickey","year":"2008","unstructured":"Hickey M et al (2008) Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol 19(10):1669\u20131680","journal-title":"Ann Oncol"},{"issue":"11","key":"10041_CR42","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrc1992","volume":"6","author":"V Stearns","year":"2006","unstructured":"Stearns V et al (2006) Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. Nat Rev Cancer 6(11):886\u2013893","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10041_CR43","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/1097-0142(19830301)51:5<803::AID-CNCR2820510509>3.0.CO;2-V","volume":"51","author":"AM Dnistrian","year":"1983","unstructured":"Dnistrian AM et al (1983) Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients. Cancer 51(5):803\u2013807","journal-title":"Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10041-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-10041-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10041-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:29:12Z","timestamp":1769743752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-10041-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10041"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-10041-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6106285\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There should be two IRB approval for this paper, (IRB No. H-1105\u2013092\u2013363) and (IRB No. H-2412-015-1592).","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Biomedical Research Ethics Committee of Seoul National University Hospital (Seoul, South Korea) and was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors of this study have agreed to submit and publish it in this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"945"}}